Pulmicort flexhaler and Bactrim drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pulmicort flexhaler (budesonide) and Bactrim (sulfamethoxazole; trimethoprim). Common drug interactions include pulmonary arterial hypertension among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Pulmicort flexhaler and Bactrim. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Pulmicort flexhaler?

Pulmicort flexhaler has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 5,527 Pulmicort flexhaler users. Check the latest studies of Pulmicort flexhaler.

What is Bactrim?

Bactrim has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 89,117 Bactrim users. Check the latest studies of Bactrim.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 23, 2026

24 people who take Pulmicort flexhaler and Bactrim together, and have interactions are studied.

Pulmicort flexhaler and Bactrim drug interactions.

What are the common drug interactions of Pulmicort Flexhaler and Bactrim, by gender? *:

female:

  1. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  2. Pulmonary oedema (fluid accumulation in the lungs)
  3. Rash
  4. Road traffic accident
  5. Swelling face
  6. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  7. Throat irritation
  8. Drug ineffective
  9. Pyrexia (fever)
  10. Dyspnoea (difficult or laboured respiration)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Renal injury (kidney injury)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Abdominal discomfort
  6. Blood creatinine increased
  7. Compression fracture (fracture due to pressure caused by injury)
  8. Drug ineffective
  9. Fatigue (feeling of tiredness)
  10. Non-cardiac chest pain

What are the common drug interactions of Pulmicort Flexhaler and Bactrim, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Drug ineffective
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Emotional distress
  6. Pain
  7. Renal failure (kidney dysfunction)
  8. Renal injury (kidney injury)
  9. Traumatic lung injury
  10. Abdominal discomfort

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Pyrexia (fever)
  3. Application site scar
  4. Arthralgia (joint pain)
  5. Asthenia (weakness)
  6. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  7. Chills (felling of cold)
  8. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  9. Decreased appetite
  10. Dehydration (dryness resulting from the removal of water)

What are the existing conditions these people have? *

  1. Pain: 5 people, 20.83%
  2. High Blood Pressure: 5 people, 20.83%
  3. Sinusitis (inflammation of sinus): 4 people, 16.67%
  4. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 12.50%
  5. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 12.50%
  6. Multiple Allergies (allergy to multiple agents): 3 people, 12.50%
  7. High Blood Cholesterol: 3 people, 12.50%
  8. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 3 people, 12.50%
  9. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 12.50%
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmicort flexhaler and Bactrim?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pulmicort flexhaler and Bactrim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pulmicort flexhaler:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bactrim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pulmicort flexhaler and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bactrim and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on budesonide and sulfamethoxazole; trimethoprim (the active ingredients of Pulmicort flexhaler and Bactrim, respectively), and Pulmicort flexhaler and Bactrim (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: